Abstract:Huntington's disease (HD) predominantly affects the brain, causing a mixed movement disorder, cognitive decline and behavioural abnormalities. It also causes a peripheral phenotype involving skeletal muscle. Mitochondrial dysfunction has been reported in tissues of HD models, including skeletal muscle, and lymphoblast and fibroblast cultures from patients with HD. Mutant huntingtin protein (mutHTT) expression can impair mitochondrial quality control and accelerate mitochondrial ageing.Here, we obtained fresh human skeletal muscle, a post-mitotic tissue expressing the mutated HTT allele at physiological levels since birth, and primary cell lines from HTT CAG repeat expansion mutation carriers and matched healthy volunteers to examine whether such a mitochondrial phenotype exists in human HD. Using ultra-deep mitochondrial DNA (mtDNA) sequencing, we showed an accumulation of mtDNA mutations affecting oxidative phosphorylation. Tissue proteomics indicated impairments in mtDNA maintenance with increased mitochondrial biogenesis of less efficient oxidative phosphorylation (lower complex I and IV activity). In full-length mutHTT expressing primary human cell lines, fission-inducing mitochondrial stress resulted in normal mitophagy. In contrast, expression of high levels of N-terminal mutHTT fragments promoted mitochondrial fission and resulted in slower, less dynamic mitophagy. Expression of high levels of mutHTT fragments due to somatic nuclear HTT CAG instability can thus affect mitochondrial network dynamics and mitophagy, leading to pathogenic mtDNA mutations.We show that life-long expression of mutant HTT causes a mitochondrial phenotype indicative of mtDNA instability in fresh post-mitotic human skeletal muscle. Thus, genomic instability may not be limited to nuclear DNA, where it results in somatic expansion of the HTT CAG repeat length in particularly vulnerable cells such as striatal neurons. In addition to efforts targeting the causative mutation, promoting mitochondrial health may be a complementary strategy in treating diseases with DNA instability such as HD. Neueder et al. reveal an accumulation of mitochondrial DNA mutations and impairments in mitochondrial quality control in fresh skeletal muscle samples from patients with Huntington's disease. Accelerated mitochondrial ageing may thus be one of the biological signatures of Huntington's disease, including in peripheral tissues.

A Comprehensive Perspective of Huntington's Disease and Mitochondrial Dysfunction.

A comprehensive perspective of Huntington?s disease and mitochondrial dysfunction

Mitochondrial Dysfunction and Huntington Disease.

A Mitochondria-Associated Oxidative Stress Perspective on Huntington’s Disease

Huntington's Disease: Molecular Basis of Pathology and Status of Current Therapeutic Approaches.

Huntington’s Disease: Complex Pathogenesis and Therapeutic Strategies

Increased mitochondrial fission and neuronal dysfunction in Huntington's disease: implications for molecular inhibitors of excessive mitochondrial fission

Exploring molecular mechanisms, therapeutic strategies, and clinical manifestations of Huntington's disease

Complex Pathogenesis and Therapeutic Strategies

Metabolic dysregulation in Huntington's disease: Neuronal and glial perspectives

Huntington's Disease Affects Mitochondrial Network Dynamics Predisposing to Pathogenic Mitochondrial DNA Mutations

Mitochondria in Huntington’s disease: implications in pathogenesis and mitochondrial-targeted therapeutic strategies

Huntington disease affects mitochondrial network dynamics predisposing to pathogenic mtDNA mutations

Advances in Gene and Cellular Therapeutic Approaches for Huntington’s Disease

Molecular Mechanisms Underlying Muscle Wasting in Huntington’s Disease

Insights into Mechanisms, Diagnosis, and Therapeutic Implications

Latest Advances on New Promising Molecular-Based Therapeutic Approaches for Huntington’s Disease

Huntington’s Disease: Relationship Between Phenotype and Genotype

Soluble N-terminal Fragment of Mutant Huntingtin Protein Impairs Mitochondrial Axonal Transport in Cultured Hippocampal Neurons.

Huntington's Disease: Latest Frontiers in Therapeutics

N-Terminal Mutant Huntingtin Associates with Mitochondria and Impairs Mitochondrial Trafficking